Latest Articles

Publication Date
All News Scientific
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Yahoo! Finance Canada

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer Yahoo! Finance …

Published: May 18, 2026, 10:45 a.m.
Read Full Article
Endometriosis Ovarian Cancer Risk Needs Context - EMJ

Endometriosis Ovarian Cancer Risk Needs Context EMJ

Published: May 17, 2026, 9:32 p.m.
Read Full Article
GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug - MSN

GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug MSN

Published: May 17, 2026, 7:18 p.m.
Read Full Article
East of England Hospitals Trial Less Invasive Womb Cancer Test - world.infonasional.com

East of England Hospitals Trial Less Invasive Womb Cancer Test world.infonasional.com

Published: May 17, 2026, 5:41 a.m.
Read Full Article
'New cancer test makes me feel women's health matters' - BBC

'New cancer test makes me feel women's health matters' BBC

Published: May 17, 2026, 5:37 a.m.
Read Full Article
Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making.

Endometriosis, particularly ovarian endometrioma, is associated with a 2-fold increased risk of ovarian cancer (OC), especially the clear cell and endometrioid subtypes. However, the absolute lifetime risk of OC in …

Published: May 17, 2026, midnight
Read Full Article
biomarkers contraception endometriosis hormonal treatment oral contraceptives ovarian cancer surgery survival ultrasound
University explores endometriosis and cancer link - AOL.com

University explores endometriosis and cancer link AOL.com

Published: May 16, 2026, 7:16 p.m.
Read Full Article
The Four Types of Therapy for Second-Line Endometrial Cancer - CancerNetwork

The Four Types of Therapy for Second-Line Endometrial Cancer CancerNetwork

Published: May 16, 2026, 2:04 p.m.
Read Full Article
Antibody-Drug Conjugate Shows Activity in Hard-to-Treat Uterine Cancer - Inside Precision Medicine

Antibody-Drug Conjugate Shows Activity in Hard-to-Treat Uterine Cancer Inside Precision Medicine

Published: May 15, 2026, 7:12 p.m.
Read Full Article
Navigating the Evolving Landscape of Second-Line Endometrial Cancer Care - CancerNetwork

Navigating the Evolving Landscape of Second-Line Endometrial Cancer Care CancerNetwork

Published: May 15, 2026, 2:05 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!